Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10350213 Methods for treating cancer using apilimod

Patent 10350213 was granted and assigned to AI Therapeutics on July, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

OrphAI Therapeutics

Current Assignee

OrphAI Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

103502130

Patent Inventor Names

Tian Xu0

Paul Beckett0

Sean Landrette0

Sophia Gayle0

Chris Conrad0

Henri Lichenstein0

Jonathan M. Rothberg0

Neil Beeharry0

Date of Patent

July 16, 2019

Patent Application Number

152138290

Date Filed

July 19, 2016

Patent Citations Received

‌

US Patent 10765682 Apilimod for use in the treatment of melanoma

‌

US Patent 11266654 Apilimod compositions and methods for using same

Patent Primary Examiner

‌

Samira J Jean-Louis

Patent abstract

The present invention relates to methods for treating cancer with apilimod and related compositions and methods.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10350213 Methods for treating cancer using apilimod

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API